Concepedia

Author

Lucas J. Aponte‐Collazo

University of North Carolina at Chapel HillORCID

Also Known As

Aponte-Collazo, Lucas J., Lockett, Matthew R., Lucas Aponte-Collazo, Lucas J. Aponte-Collazo, Lucas J. Aponte‐Collazo, Rushing, Blake R.

18

Publications

270

Citations

5

H-Index

0

Concepts

All Affiliations

University of North Carolina at Chapel HillMadera BioSciences (United States)NewYork–Presbyterian Brooklyn Methodist HospitalInstitute of Theoretical and Experimental BiophysicsNational Cancer Institute
LJ

About

Lucas J. Aponte‐Collazo is an author at University of North Carolina at Chapel Hill.

Lucas J. Aponte‐Collazo

×

3

Publications

250

Citations

3

H-Index

YearCitations

Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues

Paul R. Graves, Lucas J. Aponte‐Collazo, Emily M.J. Fennell,

ACS Chemical Biology

2019

195

Characterization of <scp>TR</scp> ‐107, a novel chemical activator of the human mitochondrial protease <scp>ClpP</scp>

Emily M.J. Fennell, Lucas J. Aponte‐Collazo, Joshua D. Wynn,

Pharmacology Research & Perspectives

2022

36

Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer

Emily M.J. Fennell, Lucas J. Aponte‐Collazo, Wimal Pathmasiri,

Frontiers in Pharmacology

2023

19

Page 1